Esperion Therapeutics Inc. (NASDAQ:ESPR) does about 6.26M shares in volume on a normal day but saw 4791912 shares change hands in Monday trading. The company now has a market cap of 325.50M USD. Its current market price is $1.91, marking a decrease of -2.05% compared to the previous close of $1.95. The 52 week high reached by this stock is $3.40 whilst the lowest price level in 52 weeks is $0.70.
Esperion Therapeutics Inc. (ESPR) has a 20-day trading average at $2.4983 and the current price is -43.82% off the 52-week high compared with 172.86% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.4461 and its 200-day simple moving average is $1.7800. If we look at the stock’s price movements over the week, volatility stands at 10.17%, which increases to 12.80% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 36.07 to suggest the stock is neutral.
The consensus objective for the share price is $7.41, suggesting that the stock has a potential upside of 74.22% over the period.
Esperion Therapeutics Inc. (ESPR) stock is down -1.29% over the week and -9.48% over the past month. Its price is -36.12% year-to-date and 49.22% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/31/2023, with the company’s earnings per share (EPS) of -$0.5 below consensus estimates by -$0.02. ESPR’s earnings per share are forecast to grow by 80.30% this year and 112.50% over next year. Expected sales for next quarter are $42.53 million, which analysts say will come at $265.13 million for the current fiscal year and next year at $391.03 million. In addition, estimates put the company’s current quarterly revenue at an average of $84.51 million.
To reach the target analysts have set, the stock logically needs to grow 74.22 percent from here.
The company has a return on investment of -422.11%. The forward price to earnings ratio is 36.30. The beta has a value of 0.90. Price to sales ratio is 2.80.
